NasdaqGM:ADMABiotechs
Has The Recent 53% ADMA Biologics (ADMA) Slide Opened A Valuation Opportunity?
If you are wondering whether ADMA Biologics at US$10.49 is a bargain or a value trap, the key is to understand what the current price actually implies about the business.
The stock has been volatile, with a 13.3% return over the last 7 days, a 30.8% decline over 30 days, a 41.3% decline year to date, and a 52.6% decline over the last year, set against a very large 3 year return and almost 7x over 5 years.
Recent coverage has focused on the stock's sharp pullback over the past month and year,...